Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

EGX:MPCI Balance Sheet

Financials in millions EGP. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	611.39	678.63	519.86	143.53	83.83
Cash & Short-Term Investments	611.39	678.63	519.86	143.53	83.83
Cash Growth	-9.91%	30.54%	262.20%	71.22%	59.38%
Accounts Receivable	126.38	189.23	338.14	335.75	78.66
Other Receivables	-	-	-	-	40.02
Receivables	299.76	261.89	338.14	335.75	208.19
Inventory	460.89	452.6	254.53	221.22	172.55
Prepaid Expenses	-	-	-	-	1.9
Other Current Assets	-0	-	-	-	14.14
Total Current Assets	1,372	1,393	1,113	700.49	480.61
Property, Plant & Equipment	108.79	86.9	86.48	63.5	54.63
Long-Term Investments	6.49	6.49	6.49	6.49	6.49
Other Intangible Assets	1.56	5.2	8.83	12.46	16.1
Long-Term Deferred Tax Assets	1.01	1.1	2.72	2.72	2.47
Other Long-Term Assets	-	-0	-0	-	0
Total Assets	1,490	1,493	1,217	785.66	560.29

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	322.73	354.6	639.77	589.12	461.44
Accrued Expenses	-	-	-	12.34	10.15
Short-Term Debt	21.91	21.91	67.5	10.98	4.73
Current Unearned Revenue	-	-	-	0.09	0.09
Other Current Liabilities	250.83	272.73	248.7	64.27	45.68
Total Current Liabilities	595.47	649.24	955.97	676.8	522.08
Long-Term Debt	51.12	73.03	109.54	2.34	-
Long-Term Deferred Tax Liabilities	-	-	2.45	1.57	1.57
Other Long-Term Liabilities	-	0	-0	-	-
Total Liabilities	646.59	722.27	1,068	680.7	523.65

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	227.5	227.5	56.25	56.25	56.25
Retained Earnings	611.86	539.54	89.34	45.61	-22.7
Comprehensive Income & Other	3.93	3.49	3.49	3.09	3.09
Shareholders' Equity	843.29	770.54	149.08	104.95	36.64
Total Liabilities & Equity	1,490	1,493	1,217	785.66	560.29

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	73.03	94.94	177.04	13.32	4.73
Net Cash (Debt)	538.36	583.69	342.81	130.21	79.1
Net Cash Growth	-7.77%	70.27%	163.29%	64.62%	67.45%
Net Cash Per Share	23.67	25.65	60.94	23.15	14.06
Filing Date Shares Outstanding	22.75	22.75	5.63	5.63	5.63
Total Common Shares Outstanding	22.75	22.75	5.63	5.63	5.63
Working Capital	776.56	743.88	156.56	23.7	-41.47
Book Value Per Share	37.07	33.87	26.50	18.66	6.51
Tangible Book Value	841.73	765.34	140.25	92.49	20.55
Tangible Book Value Per Share	37.00	33.64	24.93	16.44	3.65
Land	0.59	0.59	0.59	0.59	0.59
Buildings	108.8	99.35	93.19	60.56	60.56
Machinery	212.9	179.47	148.08	141.61	141.61
Construction In Progress	7.95	11.42	20.05	38.51	27.54

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error